Pancreatic Cancer Research

ResearcherUniversity of Newcastle AustraliaNo recent work listed

Hong Ngoc Thuy Pham

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6722-8910; OpenAlex author ID A5013469322. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Novel piperazine-1,2,3-triazole leads for the potential treatment of pancreatic cancer. Co-author DOI 10.1039/d2md00289b↗
  2. In vitro anti-pancreatic cancer activity of HPLC-derived fractions from Helicteres hirsuta Lour. stem. Co-author DOI 10.1007/s11033-019-05180-0↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christopher James Scarlett · 2 shared papers, 2020–2023 · strength 0.35
  2. Adam McCluskey · 1 shared paper, 2023 · strength 0.18
  3. Chloé Goldsmith · 1 shared paper, 2023 · strength 0.18
  4. Ju‐Feng Sun · 1 shared paper, 2023 · strength 0.18
  5. Quan V. Vuong · 1 shared paper, 2020 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.